Drug-drug interaction trial with sovaprevir [ACH 1625] and ACH 3102 in healthy subjects.

Trial Profile

Drug-drug interaction trial with sovaprevir [ACH 1625] and ACH 3102 in healthy subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 23 Apr 2013

At a glance

  • Drugs Odalasvir (Primary) ; Sovaprevir (Primary)
  • Indications Hepatitis C
  • Focus Adverse reactions
  • Most Recent Events

    • 23 Apr 2013 Results reported at International Liver Congress 2013 at the 48th Annual Meeting of the European Association for the Study of the Liver (EASL), according to an Achillion media release.
    • 12 Nov 2012 Results reported in an Achillion Pharmaceuticals media release.
    • 12 Nov 2012 Status changed from planning to completed, based on an Achillion Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top